Anselm Pharmaceuticals Private Limited, a active private limited company, was established on 08 February 2016 in Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74994MH2016PTC272897. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Siddhi Sushil Parab (Additional Director), Rajshri Ramchandra Dhamankar (Additional Director). Past directors included Mamta Pramod Castelino, Pramod John Castelino. It holds ₹1.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Shop No. 21 & 22, Kris Korner Commercial Plaza, Opposite Swastik, Thane, Maharashtra, 400607.
U74994MH2016PTC272897
272897
08 February 2016
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Anselm Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Siddhi Sushil Parab | Additional Director | 21 Dec 2022 | Current |
| Rajshri Ramchandra Dhamankar | Additional Director | 21 Dec 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Dec 2022 | Past |
| Pramod Abcsdd | Director | 22 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Anselm Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 56.73% decrease. The company also saw a substantial fall in profitability, with a 94.39% decrease in profit. The company's net worth moved up by a moderate rise of 4.7%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Anselm Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹15,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2021 | Hdfc Bank Limited | ₹1.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Anselm Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Anselm Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anselm Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Anselm Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
Progress on Anselm Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was documented.
Progress on Siddhi Sushil Parab was appointed as a Additional Director was appointed as a Additional Director on 21 Dec 2022 & has been associated with this company since 3 years 3 days . was documented.
Progress on Rajshri Ramchandra Dhamankar was appointed as a Additional Director was appointed as a Additional Director on 21 Dec 2022 & has been associated with this company since 3 years 3 days . was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 15.00 M with Charge ID 100438368 was registered on 05 Mar 2021. was completed.
Anselm Pharmaceuticals Private Limited was registered on 08 Feb 2016 with Roc Mumbai & aged 9 years 10 months as per MCA records. was recorded as a recent event.
The CIN of Anselm Pharmaceuticals Private Limited is U74994MH2016PTC272897.
Anselm Pharmaceuticals Private Limited is headquartered at Shop No. 21 & 22, Kris Korner Commercial Plaza, Opposite Swastik, Thane, Maharashtra, 400607.
Anselm Pharmaceuticals Private Limited was incorporated on 08 February 2016.
The current directors of Anselm Pharmaceuticals Private Limited are
The primary industry of Anselm Pharmaceuticals Private Limited is Trade.
Anselm Pharmaceuticals Private Limited is unlisted.
The authorized capital of Anselm Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Anselm Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX